Condition: Alzheimer Disease · Dementia · Mild Cognitive Impairment · Sponsor: Oregon Health and Science University
The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. Detect retinal blood vessel and blood flow changes in participants with dementia. 2. Detect amyloid protein deposits in the retinas of participants with dementia.
This description comes directly from the study's public registry record.
Denzil Romfh, OD · 503-494-4351 · romfhd@ohsu.edu
Humberto Martinez, COT · 503-494-7712 · martinhu@ohsu.edu
Always discuss trial participation with your own doctor first.
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03761381